Melanoma-stroma interactions: Structural and functional aspects

Lancet Oncology

Volumn 3, Issue 1, 2002, Pages 35-43

  Ruiter, Dirk ^a,c   Bogenrieder, Thomas ^a   Elder, David ^b   Herlyn, Meenhard ^a  

^a WISTAR INSTITUTE   (United States)

^b UNIVERSITY OF PENNSYLVANIA   (United States)

^c RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

CANCER GROWTH; CANCER INVASION; CELL CONTACT; CELL DIFFERENTIATION; CYTOPATHOLOGY; FIBROBLAST; HUMAN; HYPOTHESIS; MALIGNANT TRANSFORMATION; MELANOMA; METASTASIS POTENTIAL; MOLECULAR BIOLOGY; MYOFIBROBLAST; PRIORITY JOURNAL; REVIEW; STROMA; TUMOR IMMUNOLOGY; TUMOR REGRESSION; UVEA MELANOMA;

EID: 0036163492     PISSN: 14702045     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1470-2045(01)00620-9     Document Type: Review

References (75)

1. The hallmarks of cancer
2. The influence of the microenvironment on the malignant phenotype
3. Tumor progression: Defining the soil round the tumor seed
4. Cancer metastasis and angiogenesis: An imbalance of positive and negative regulation
5. Cutaneous melanoma
6. Molecular Biology of Cutaneous Melanoma
7. Genomic analysis of metastasis reveals an essential role for RhoC
8. Molecular classification of cutaneous malignant melanoma by gene expression profiling
9. Modulation of the organ microenvironment for the treatment of cancer metastasis
10. Atypical melanocytic nevi of the genital type with a discussion of reciprocal parenchymal-stromal interactions in the biology of neoplasia
11. Melanoma and stroma: An interaction of biological and prognostic importance
12. Growth factors and melanomas
13. Differential expression of basic fibroblast growth factor (bFGF) in melanocytic lesions demonstrated by in situ hybridization
14. Molecular cloning of fibroblast activation protein α, a member of the serine protease family selectively expressed in stromal fibroblasts of epithelial cancers
15. Angiogenesis and tumor progression of melanoma. Quantification of vascularity in melanocytic nevi and cutaneous malignant melanoma
16. Vascular density in melanoma xenografts correlates with vascular permeability factor expression but not with metastatic potential
17. Angiogenesis is prognostically important in vertical growth phase melanomas
18. The morphological characteristics of tumor blood vessels as a marker of tumor progression in primary human uveal melanoma: A matched case-control study
19. Reassessment of the PAS patterns in uveal melanoma
20. Diagnosis and Treatment of Uveal Melanoma
21. Uveal Melanoma: Detection of Extraocular Growth with MR Imaging and US
22. Correlation of ultrasound parameter imaging with microcirculatory patterns in uveal melanomas
23. Microcirculation architecture of melanocytic nevi and malignant melanomas of the ciliary body and choroid. A comparative histopathologic and ultrastructural study
24. Presence of a fluid-conducting meshwork in xenografted cutaneous and primary human uveal melanoma
25. Vascular channel formation by human melanoma cells in vivo and in vitro: Vasculogenic mimicry
26. Expression of type VI collagen in uveal melanoma: Its role in pattern formation and tumor progression
27. Vasculogenic mimicry: How convincing, how novel, and how significant?
28. Evaluation of the Human Choroidal Melanoma Rabbit Model for Studying Microcirculation Patterns with Confocal ICG and Histology
29. Establishment of IPC 227 cells as human xenografts in rabbits: A model of uveal melanoma
30. Morphologic diversity in malignant melanomas
31. Parenchymal-stromal interactions in neoplasia. Theoretical considerations and observations in melanocytic neoplasia
32. Morphological and immunophenotypic variations in malignant melanoma
33. Prognostic significance of periodic acid-schiff-positive patterns in primary cutaneous melanoma
34. Tumor progression, early diagnosis and prognosis of melanoma
35. Analysis of the tumor vasculature and metastatic behavior of xenografts of human melanoma cell lines transfected with vascular permeability factor
36. Interactions of melanocytes and melanoma cells with the microenvironment
37. Autocrine and paracrine regulation by cytokines and growth factors in melanoma
38. A secreted FGF-binding protein can serve as the angiogenic switch in human cancer
39. Basic fibroblast growth factor and ultraviolet B transform melanocytes in human skin
40. Platelet-derived growth factor (PDGF) in oncogenesis: Development of a vascular connective tissue stroma in xenotransplanted human melanoma producing PDGF-BB
41. Platelet-derived growth factor indirectly stimulates angiogenesis in vitro
42. Vascular permeability factor/vascular endothelial growth factor, microvascular hyperpermeability, and angiogenesis
43. Transition of horizontal to vertical growth phase melanoma is accompanied by induction of vascular endothelial growth factor expression and angiogenesis
44. Prognostic value of tumour vascularity in metastatic melanoma and association of blood vessel density with vascular endothelial growth factor expression
45. Angiogenesis in cancer and other diseases
46. Matrix metalloproteinases in human melanoma
47. Role of interleukin-8 in tumor growth and metastasis of human melanoma
48. Involvement of CD 44 in matrix metalloproteinase-2 regulation in human melanoma cells
49. Dynamics of intercellular communication during melanoma development
50. Circulating endothelial precursors: Mystery, reality, and promise
51. The cellular derivation and the life span of the myofibroblast
52. Myofibroblasts I. Paracrine cells important in health and disease
53. Heterotypic signaling between epithelial tumor cells and fibroblasts in carcinoma formation
54. ECM and cell surface proteolysis: Regulating cellular ecology
55. Cancer invasion and tissue remodeling - Cooperation of protease systems and cell types
56. The transcriptional program in the response of human fibroblasts to serum
57. Tumors: Wounds that do not heal. Similarities between tumor stroma generation and wound healing
58. Isolation of putative progenitor endothelial cells for angiogenesis
59. Bone marrow mesenchymal stem cells serve as precursors for stromal fibroblasts in solid tumors
60. Cytokines and cancer
61. Landscaping the cancer terrain
62. Extracellular matrix signaling: Integration of form and function in normal and malignant cells
63. A new American joint committee on cancer staging system for cutaneous melanoma
64. Inflammation and cancer: Back to Virchow?
65. The urokinase-type plasminogen activator system in cancer metastasis: A review
66. Expression of interleukin-8 detected by in situ hybridization correlates with worse prognosis in primary cutaneous melanoma
67. Increased serum concentration of angiogenic factors in malignant melanoma patients correlates with tumor progression and survival
68. High tPA-expression in primary melanoma of the limb correlates with good prognosis
69. Prognostic value of MMP2 immunoreactive protein (72 kD type IV collagenase) in primary skin melanoma
70. Tumour metastasis: Is tissue an issue?
71. Compartmental distribution of tumor-specific monoclonal antibodies in human melanoma xenografts
72. Barriers to drug delivery in solid tumors
73. The microenvironment of the tumour-host interface
74. Antisense targeting of basic fibroblast growth factor and fibroblast growth factor receptor-1 in human melanomas blocks intratumoral angiogenesis and tumor growth
75. Combining suramin and a chimeric toxin directed to basic fibroblast growth factor receptors increased therapeutic efficacy against human melanoma in an animal model